思创医惠科技股份有限公司第六届董事会提名委员会 关于第六届董事会独立董事候选人任职资格的审查意见 思创医惠科技股份有限公司（以下简称"公司"）第六届董事会提名委员会 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司独立 董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》（以下简称"《规范运作》"）等法律法规、规范性文件和《公 司章程》的相关规定，对公司第六届董事会独立董事候选人何毅琦先生的任职资 格进行了审查，并发表审查意见如下： 一、独立董事候选人何毅琦先生符合《上市公司独立董事管理办法》等法律 法规规定的独立董事任职资格和独立性要求，具备履行独立董事职责的专业知识、 工作经验和职业素养，不存在《公司法》《规范运作》等法律法规和《公司章程》 中规定的不得担任董事、独立董事的情形，不存在被中国证监会确定为市场禁入 者且尚未解除的情况，不存在重大失信等不良记录，也未曾受到中国证监会和证 券交易所的处罚和惩戒，具备担任上市公司独立董事的履职能力。 二、独立董事候选人何毅琦先生尚未取得独立董事资格证书，其已书面承诺 参加最近一次独立董事培训并取得深圳证券交易 ...

Group 1 - Dingjide's subsidiary has successfully launched the industrial production of POE materials, achieving stable production of qualified products [1] - Xinhua Insurance reported a 19% year-on-year increase in original insurance premium income for the first three quarters, totaling 172.705 billion yuan [1] - Chunfeng Power achieved a 30.89% year-on-year increase in net profit for the first three quarters, with total revenue reaching 14.15 billion yuan [1][2] Group 2 - Guangsheng Nonferrous expects a net profit of 100 million to 130 million yuan for the first three quarters, marking a turnaround from losses [1] - Aobi Zhongguang anticipates a net profit of approximately 108 million yuan for the first three quarters, with revenue growth of 103.5% [1] - Guobang Pharmaceutical reported a 15.78% year-on-year increase in net profit for the first three quarters, totaling 6.7 billion yuan [1] Group 3 - Zhujiang Co. manages 428 projects with a signed construction area of approximately 50.9853 million square meters as of September 2025 [1] - Kecuan Technology has terminated its application for issuing convertible bonds, considering its development plan and actual situation [1] - Guoxin Securities has received approval to register 15 billion yuan in short-term corporate bonds [1] Group 4 - Aihua Pharmaceutical's clinical trial for a pediatric cough syrup has been approved by the National Medical Products Administration [1] - Xinjiang Jiaojian signed new construction contracts worth 1.413 billion yuan in the third quarter [1] - Sichuan Shuangma's subsidiary has received approval for the listing of a raw material drug used in treating various diseases [1] Group 5 - Gansu Energy's 1,000 MW coal-fired unit has officially commenced commercial operation [1] - Zhejiang Energy reported a 4.68% year-on-year increase in power generation for the first three quarters, totaling 135.234 billion kWh [1] - Tiandi Source's contract sales amount for the first nine months decreased by 16.18% to 3.085 billion yuan [1] Group 6 - Biological Shares' subsidiary has obtained a new veterinary drug registration certificate for a vaccine [1] - Jintong Co. reported a 4.03% year-on-year increase in net profit for the first three quarters, totaling 2.283 billion yuan [1] - Rihua Technology plans to invest 800 million yuan in a new project for industrial ray detection equipment [1] Group 7 - Zhongtian Technology has won multiple marine project bids totaling approximately 1.788 billion yuan [1] - Qingsong Co. has completed the disposal of a 148-acre industrial park project, transferring it for 163 million yuan [1] - Tongyuan Petroleum has successfully bid for a $126 million oil and gas service project in Algeria [1] Group 8 - Hengmingda's chairman proposed a share buyback plan of 200 million to 400 million yuan [1] - Deyi Cultural plans to reduce its holdings by up to 1% of the company's shares [1] - Feirongda's major shareholder plans to reduce its holdings by up to 2.36% of the company's shares [1] Group 9 - Mankun Technology plans to issue convertible bonds to raise no more than 760 million yuan for high-end PCB production and digital upgrades [1] - Sanlian Forging's shareholder plans to reduce its holdings by up to 3% of the company's shares [1] - Huagong Technology intends to jointly establish a venture capital fund with a target size of 500 million yuan [1] Group 10 - Shida Shenghua expects a net loss of 49 million to 75 million yuan for the first three quarters [1] - Huichuangda's major shareholder plans to reduce its holdings by up to 0.65% of the company's shares [1] - Yuxin Electronics reported a 60.21% year-on-year increase in net profit for the first three quarters, totaling 73.3941 million yuan [1] Group 11 - Yiwei Communication expects a 50% to 55% decline in net profit for the first three quarters [1] - Lio Co. plans to reduce its repurchased shares by up to 135 million shares [1] - Sichuan Shuangma's subsidiary has received approval for a new drug registration [1]

Core Insights - The internet healthcare sector experienced a decline of 0.59% on October 16, with Rongke Technology leading the drop [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Stock Performance - Notable gainers in the internet healthcare sector included: - Wanma Technology (300698) with a closing price of 50.09, up 10.94% and a trading volume of 237,000 shares, totaling 1.177 billion yuan [1] - Fengzhou Ziling (002424) at 5.95, up 9.98% with a volume of 482,600 shares, totaling 281 million yuan [1] - New Mileage (002219) at 2.45, up 9.87% with a volume of 3.4548 million shares, totaling 833 million yuan [1] - Decliners included: - Moke Technology (300290) at 22.16, down 8.54% with a volume of 435,700 shares, totaling 976 million yuan [2] - Zhongyuan Shares (300018) at 10.45, down 6.28% with a volume of 472,200 shares, totaling 500 million yuan [2] Capital Flow - The internet healthcare sector saw a net outflow of 702 million yuan from institutional investors, while retail investors contributed a net inflow of 343 million yuan [2][3] - Key stocks with significant capital flow included: - New Mileage (002219) with a net inflow of 1.59 billion yuan from institutional investors, but a net outflow from retail investors [3] - Wanma Technology (300698) with a net inflow of 146 million yuan from institutional investors [3]

Core Insights - On October 16, 2023, 13 companies released their Q3 2025 financial reports, with 12 reporting year-on-year profit growth and 10 showing revenue growth [1] - Guanghua Technology reported the highest profit growth at 1233.70%, indicating a significant performance increase [1] Summary by Category Profit Performance - Guanghua Technology: Net profit of 90.39 million yuan, up 1233.70% YoY [1] - Yuxin Electronics: Net profit of 73.39 million yuan, up 60.21% YoY [1] - Xinzhi Group: Net profit of 121.51 million yuan, up 39.49% YoY [1] - Haiguang Information: Net profit of 196.14 million yuan, up 28.56% YoY [1] - Other companies with profit growth include Zongyi Co., Jiuzhou Pharmaceutical, and Beijing Lier [1] Revenue Performance - Guanghua Technology: Revenue of 2.04 billion yuan, up 11.50% YoY [1] - Yuxin Electronics: Revenue of 572.13 million yuan, up 40.97% YoY [1] - Haiguang Information: Revenue of 948.99 million yuan, up 54.65% YoY [1] - Other companies with revenue growth include Zongyi Co., Jiuzhou Pharmaceutical, and Beijing Lier [1] Companies with Declining Performance - Qin Chuan Wulian: Reported a net loss of 69.90 million yuan, down 66.72% YoY [1] - Xue Rong Biological: Net loss of 62.35 million yuan, up 61.94% YoY [1] - Other companies with declining revenue include Xue Rong Biological and Qin Chuan Wulian [1]

Core Insights - As of October 16, 2023, 25 companies have released their Q3 2025 financial reports, with 23 reporting year-on-year profit growth and 18 showing revenue growth [1] - The company with the highest profit growth is Guanghua Technology, with a staggering increase of 1233.70% [1] Financial Performance Summary - **Profit Growth**: 23 companies reported profit growth, while 2 experienced declines [1] - **Revenue Growth**: 18 companies reported revenue growth, with 7 showing declines [1] - **Notable Performers**: Guanghua Technology leads with a profit of 90.39 million yuan and revenue of 2.04 billion yuan, marking a profit growth of 1233.70% and revenue growth of 11.50% [1] - **Other High Performers**: - Daoshi Technology: Profit of 415.44 million yuan, profit growth of 182.45%, revenue of 600.09 million yuan, revenue decline of 1.79% [1] - Sichuang Medical: Profit of -0.48 million yuan, profit growth of 98.32%, revenue of 60.38 million yuan, revenue growth of 6.95% [1] - Xiaogoods City: Profit of 3.46 billion yuan, profit growth of 48.45%, revenue of 13.06 billion yuan, revenue growth of 23.07% [1] Declining Performers - **Profit Declines**: Qin Chuan Technology reported a profit decline of 66.72% with a loss of 6.99 million yuan and revenue decline of 16.24% [2] - **Other Decliners**: - High Energy Environment: Profit growth of 15.18% with revenue decline of 11.28% [2] - Qifeng New Materials: Profit decline of 3.82% with revenue decline of 0.83% [2]

单看第三季度，思创医惠实现的营业收入约为5879.51万元，同比下降64.93%；对应实现的归属净利润 约为4706.93万元，同比增长177.42%。 北京商报讯（记者 丁宁）10月15日晚间，思创医惠（300078）发布2025年三季度报告显示，公司前三 季度实现的营业收入约为6.04亿元，同比增长6.95%；对应实现的归属净利润约为-476.22万元，同比增 长98.32%。 ...

Core Insights - The company reported a revenue of 604 million yuan for the first three quarters of 2025, representing a year-on-year growth of 6.95% [1] - The net loss attributable to shareholders of the listed company was 4.76 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 158 million yuan [1]

Core Insights - The company, 思创医惠, reported a significant decline in revenue for Q3 2025, with a total revenue of 58.79 million yuan, representing a year-on-year decrease of 64.93% [1] - The company achieved a net profit attributable to shareholders of 47.07 million yuan in Q3, marking a turnaround from previous losses [1] - For the first three quarters of 2025, the company recorded a net loss attributable to shareholders of 4.76 million yuan [1]

智通财经APP讯，思创医惠(300078.SZ)发布2025年三季度报告，该公司前三季度营业收入为6.04亿元， 同比增长6.95%。归属于上市公司股东的净亏损为476.22万元。归属于上市公司股东的扣除非经常性损 益的净亏损为1.58亿元。 ...

每经头条（nbdtoutiao）——出租白银的爆赚机会：年化利率飙升到35%，全球白银正空运往英国套 利，背后是一场史诗级逼空 （记者 曾健辉） 每经AI快讯，思创医惠10月15日晚间发布三季度业绩公告称，2025年前三季度营收约6.04亿元，同比增 加6.95%；归属于上市公司股东的净利润亏损约476万元。 ...